Management of Aortic Stenosis and Chronic Heart Failure: A Clinical Consensus Statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC

Transcatheter or surgical aortic valve replacement (AVR) is the evidence-based treatment of choice for severe aortic stenosis (AS) and heart failure (HF)

Multidisciplinary management involving an HF specialist is crucial, including dedicated pre-procedural HF and AS assessment and careful post-procedural follow-up with monitoring of HF status